Patient Guide: Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 14 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT06439225
Status: 🟢 Enrolling Now
Condition: Metastatic Castration-resistant Prostate Cancer, Metastatic Prostate Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 14 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Calgary, Alberta
  • • Edmonton, Alberta
  • • Vancouver, British Columbia
  • • And 11 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes - Join Clinical Trial NCTNCT06439225

How to Join This Clinical Trial - NCTNCT06439225

Learn how to participate in this PHASE3 trial studying an investigational therapy for Metastatic Castration-resistant Prostate Cancer, Metastatic Prostate Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Metastatic Castration-resistant Prostate Cancer, Metastatic Prostate Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Metastatic Castration-resistant Prostate Cancer, Metastatic Prostate Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06439225 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 14 locations. Find a study site near you:

Clinical Research Site

Calgary, Alberta T2N 5G2 - Canada

Status: RECRUITING

Clinical Research Site

Edmonton, Alberta T6G 1Z2 - Canada

Status: RECRUITING

Clinical Research Site

Vancouver, British Columbia V5Z 4E6 - Canada

Status: NOT_YET_RECRUITING

Clinical Research Site

Brampton, Ontario L6R 3J7 - Canada

Status: RECRUITING

Clinical Research Site

Kitchener, Ontario N2G 1G3 - Canada

Status: RECRUITING

Clinical Research Site

London, Ontario N6A 5W9 - Canada

Status: RECRUITING

Clinical Research Site

Ottawa, Ontario K1H 8L6 - Canada

Status: RECRUITING

Clinical Research Site

Toronto, Ontario M4N 3M5 - Canada

Status: RECRUITING

Clinical Research Site

Toronto, Ontario M5G 2M9 - Canada

Status: RECRUITING

Clinical Research Site

Montreal, Quebec H2X 3E4 - Canada

Status: RECRUITING

And 4 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Metastatic Castration-resistant Prostate Cancer, Metastatic Prostate Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation